Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (261-270 of 421) with videos related to

Pageof 43
Sort By:
Antimicrobial Agents and Chemotherapy|March 10, 2010
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health systemTara Reddy, Teena Chopra, Dror Marchaim, et al.
Infection Control and Hospital Epidemiology|September 5, 2020
Institutional quality and patient safety programs: An overview for the healthcare epidemiologistPranavi V Sreeramoju, Tara N Palmore, Grace M Lee, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2019
The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identificationOryan Henig, Christopher C Cooper, Keith S Kaye, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 30, 2023
At the vanguard: Leaders' perspectives on establishing healthcare system infection prevention programsMichael P Stevens, Sharon B Wright, Keith S Kaye, et al.
Open Forum Infectious Diseases|February 11, 2022
Daptomycin-Resistant <i>Enterococcus</i> Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver TransplantationRachael A Lee, Jason Goldman, Ghady Haidar, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2016
Correction for Hasassri et al., An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like CarbapenemaseM Earth Hasassri, Thomas G Boyce, Andrew P Norgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2019
Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial PneumoniaOwen R Albin, Oryan Henig, Twisha S Patel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2024
A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumoniaOwen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like CarbapenemaseM Earth Hasassri, Thomas G Boyce, Andrew P Norgan, et al.
Infection Control and Hospital Epidemiology|November 25, 2014
Prevalence of and risk factors for vancomycin-resistant Staphylococcus aureus precursor organisms in Southeastern MichiganValerie S Albrecht, Marcus J Zervos, Keith S Kaye, et al.
Pageof 43

Showing results (261-270 of 421) with videos related to

Sort By:
Pageof 43
Antimicrobial Agents and Chemotherapy|March 10, 2010
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health systemTara Reddy, Teena Chopra, Dror Marchaim, et al.
Infection Control and Hospital Epidemiology|September 5, 2020
Institutional quality and patient safety programs: An overview for the healthcare epidemiologistPranavi V Sreeramoju, Tara N Palmore, Grace M Lee, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2019
The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identificationOryan Henig, Christopher C Cooper, Keith S Kaye, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 30, 2023
At the vanguard: Leaders' perspectives on establishing healthcare system infection prevention programsMichael P Stevens, Sharon B Wright, Keith S Kaye, et al.
Open Forum Infectious Diseases|February 11, 2022
Daptomycin-Resistant <i>Enterococcus</i> Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver TransplantationRachael A Lee, Jason Goldman, Ghady Haidar, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2016
Correction for Hasassri et al., An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like CarbapenemaseM Earth Hasassri, Thomas G Boyce, Andrew P Norgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2019
Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial PneumoniaOwen R Albin, Oryan Henig, Twisha S Patel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2024
A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumoniaOwen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like CarbapenemaseM Earth Hasassri, Thomas G Boyce, Andrew P Norgan, et al.
Infection Control and Hospital Epidemiology|November 25, 2014
Prevalence of and risk factors for vancomycin-resistant Staphylococcus aureus precursor organisms in Southeastern MichiganValerie S Albrecht, Marcus J Zervos, Keith S Kaye, et al.
Pageof 43